The Clinical Research Associate Retention Study: A Report From the Children's Oncology Group.

Pediatric medicine often struggles to receive adequate research funding for its small, yet vulnerable population of patients. Remarkable discovery in pediatric oncology is credited in large part to the collaborative structure of its research community. The Children's Oncology Group conducts studies supported by the National Cancer Institute.

Exploring the attitudes of pediatric oncologists toward the use of laxatives for the prevention of constipation in patients undergoing active treatment: a Canadian perspective.

Background: Constipation is a common problem in pediatric oncology patients and may lead to significant consequences. There is a paucity of the published literature on the prevention of constipation in this population. The primary purpose of this study was to explore the current practice of pediatric oncologists in preventing constipation in children receiving active chemotherapy treatment, specifically during periods of intensive vincristine therapy.

Experience of adapting and implementing an evidence-based nursing guideline for prevention of diaper dermatitis in a paediatric oncology setting.

Background: Diaper dermatitis is one of the most common skin problems in children often caused by irritants that promote skin breakdown, such as moisture and faecal enzymes. It has been estimated that the incidence of diaper dermatitis is as high as 50% in children receiving chemotherapy. The scientific literature suggests a variety of preventative measures, but only a minority are systematically tested and supported by clinical evidence.